Roche Navigation Menu Roche Pro : Roche Pro
  • Contact
  • Roche Belgique
  • se connecter
  • se déconnecter
  • Language: Rochepro.be | Dutch (Belgium)
  • Recherche
Roche
  • Retour
  • Home
  • nl
  • Search
  • Close search

						
							

Searching

    • Home
    • Domaines Thérapeutiques
      Domaines Thérapeutiques Aperçu
      • Ophtalmologie
      • Oncologie
      • Cancer du poumon
      • Cancer du sein
      • Cancer du foie
    • Services
      Services Aperçu
      • ProPatient
      • Demande d'échantillons
      • Roche Medical Information
      • La sécurité des patients
      • Oncology Navigation
      • OncoCare@Home
      Projecteur OncoCare@Home

    • Produits
      Produits Aperçu
    • Education médicale
      Education médicale Aperçu
      • Roche Medical Pop-Up
      • Roche Medical Pop-Up
      Projecteur Medical Pop-Up

    • Notices
      Notices Aperçu
    • Foundation Medicine
      Foundation Medicine Aperçu
    • S'enregistrer sur RochePro
      S'enregistrer sur RochePro Aperçu
    • Home
    • Domaines Thérapeutiques
      • Ophtalmologie
      • Oncologie
        • Cancer du poumon
        • Cancer du sein
        • Cancer du foie
    • Services
      • ProPatient
      • Demande d'échantillons
      • Roche Medical Information
      • La sécurité des patients
      • Oncology Navigation
      • OncoCare@Home
    • Produits
    • Education médicale
      • Roche Medical Pop-Up
        • Roche Medical Pop-Up
    • Notices
    • Foundation Medicine
    • S'enregistrer sur RochePro
    • Contact
    • Roche Belgique
    • se connecter
    • se déconnecter
    Fermer

    1 - of résultats pour ""

    No results

    Professionnel de la santé? Inscrivez-vous pour accéder au site complet.


    Vous êtes ici:

    1. Education médicale
    2. NeuroImaging Nowdays in MS

    NeuroImaging Nowadays in multiple sclerosis (MS) 

    Dive into theory of neuroimaging and MS on a global virtual platform with renowned international speakers

    NeuroImaging Nowadays in multiple sclerosis (MS) is the most recent online platform that aims to discuss the theory and clinical practice behind neuroimaging in multiple sclerosis and beyond.

    We are presenting a course comprised of 9 modules, focusing on nine different themes in MS and its diagnosis & monitoring through neuroimaging.

    We have invited several international experts to discuss and present their opinion on the subject. We invite you to participate in this international project to learn and discover more about MS and neuroimaging.

    After you have fully taken the program and answered the quiz, you will receive a certificate of completion.

    Start developping your knowledge now and get certified!

    Register and Enroll Now

    • The purpose behind the course
      • Provide a unique learning and training experience in MS and other demyelinating diseases and Neuroimaging
      • Foster knowledge on MS diagnosis and differential diagnosis, disease monitoring, prediction of treatment response, and assessment of treatment efficacy & safety
      • Empower Neurologists, Neuroradiologists, Radiologists and Residents with an interest in MRI and MS

      Start the course now

    • MS & Neuroimaging

      Multiple sclerosis (MS) is a chronic autoimmune demyelinating inflammatory and degenerative disease of the central nervous system, characterized by the presence of inflammatory lesions in the brain and spinal cord. It is most commonly diagnosed in people in their 20s and 30s, although it can develop at any age. It is about 2 to 3 times more common in women than men. To diagnose multiple sclerosis and evaluate the progression of the disease, magnetic resonance imaging is often the most reliable test because of its high sensibility and specificity in detecting demyelinating lesions. It also allows for differential diagnosis and assessment of the response to the therapeutic.

      Start the course now

    • Learning modules

      Module 1 | MRI and the diagnosis of MS 

      • Overview of MRI in MS
      • Conventional MRI techniques
      • Current diagnostic criteria: 2017 Revised McDonald criteria

      Christian Enzinger, Austria - Lina Savsek, Slovenia

      Module 2 | MRI and MS monitoring: disease activity and progression

      • Brain MRI for MS treatment efficacy monitoring
      • Brain MRI for MS prognosis
      • Brain MRI for MS safety monitoring

      Cristina Granziera, Switzerland - Mike Wattjes, Germany

      Module 3 | MRI and multiple sclerosis misdiagnosis and differential diagnosis: Pearls and oyster

      • Reasons for misdiagnosis of MS
      • McDonald 2017 - focus on specificity
      • Red flags on imaging: MS mimics

      Mike Wattjes, Germany

      Module 4 | Radiologists and Neurologists: chances and challenges in communicating in current times

      • How to improve communication between neurology and radiology? Moving things forward
      • Standards in reporting of the neurological exam 
      • best and worst practice examples

      Alex Rovira, Spain - Jan Casselman, Belgium - Melissa Cambron, Belgium - Jaume Sastre-Garriga, Spain

      Module 5 | The role of spinal cord in MRI: diagnosing, monitoring and predicting treatment response in MS

      • Value of spinal cord MRI
      • Standardize spinal cord image acquisition
      • Spinal cord MRI: diagnosis, differential diagnosis and treatment monitoring

      Jiwon Oh, Canada - David K. B. Li, Canada

      Module 6 | Optic Nerve MRI And Optical Coherence Tomography (OCT)

      • Value of optic nerve MRI
      • Role of OCT in MS
      • Correlations between brain or optic nerve adnormalities on MRI, and retinal pathology using OCT

      Hugh Kearney, Ireland - Axel Petzold, UK

      Module 7 | MRI features of specific MS populations and other CNS inflammatory diseases

      • Pediatric MS
      • Elderly MS patients
      • Pregnancy and Breastfeeding in women with MS
      • Atypical Demyelination
      • Intricacies of progressive vs. relapsing MS

      Thomas Berger, Austria - Kerstin Hellwig , Germany - Christian Enzinger, Austria - Klaus Schmierer, UK

      Module 8 | Brain and spinal cord atrophy in clinical practice: evidence and barriers to implementation

      • Physiological atrophy & clinical relevance of volume changes in patients with MS
      • Value of volume changes to predict treatment response in patients with MS
      • Atrophy in clinical practice: evidence and barriers to implementation

      Jožef Magdič, Slovenia  - Jaume Sastre-Garriga, Spain 

      Module 9 | Neuroimaging and MS: future prospects 

      • Neuroimaging and MS: MS future prospects
      • MRI and MS: future challenges and developments
      • Neuronal repair and remyelination: from biology to therapy
      • Advanced and emerging MRI techniques
      • Other neuroimaging techniques
      • Big data and deep learning: new avenues for MRI research in MS?

      Pedro Abreu, Portugal - Daniela Jardim Pereira, Portugal - Stéphane Kremer & Jérôme De Sèze, France - João Duarte, Portugal - Cristina Granziera, Switzerland

    • Scientific Committee

      Christian Enzinger, MD, MBA, FEAN

      Neurologist

      Dept. of Neurology Medical University of Graz, Austria

      Daniela Jardim Pereira, MD

      Neuroradiologist

      Coimbra Hospital and Universitary Centre, Coimbra, Portugal

      Pedro Abreu, MD

      Neurologist

      University Hospital Center of São João, Porto, Portugal

      Moke Wattjes, MD, PHD

      Neuroradiologist

      Hannover Medical School, Germany

      Thomas Berger, MD, MSc, FEAN

      Neurologist

      Dept. of Neurology, Medical University of Vienna, Austria

      Uroš Rot, MD, PhD

      Neurologist

      University Medical Centre Ljubljana and Faculty of Medicine, University of Ljubljana, Slovenia

    Endorsements

    Endorsed by several scientific societies, including for Belgium:

    R.E.: Pharm. E. De Bruyne - M-BE-00001695 - created on 26/09/2022
    • © 2023 Roche Belgium
    • 13.01.2023
    • Sitemap
    • Conditions d’utilisation
    • Politique de confidentialité
    • Politique de Cookie
    • Cookie settings

    Ce site internet contient des informations sur des produits qui s'adressent à un large public et peut contenir des renseignements ou informations sur différents produits qui ne sont pas accessibles ou valables dans votre pays. Nous déclinons toute responsabilité quant à l'accès à de telles informations qui ne seraient pas conformes à toute exigence légale, réglementation, enregistrement ou usage en vigueur dans votre pays d'origine.